![Michael Kelliher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/05/2026
Michael Kelliher currently works at Capricor Therapeutics, Inc., as Independent Director from 2023 and Ardelyx, Inc., as Chief Business Officer from 2025.
Mr. Kelliher also formerly worked at Horizon Therapeutics Ltd. (Ireland), as Group Vice President-Merger & Acquisition.
Mr. Kelliher received his undergraduate degree from University College Cork.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ARDELYX, INC. 0,14% | 21/05/2026 | 357.418 ( 0,14% ) | 2 M $ | 31/05/2026 |
| 28/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/09/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | 25/03/2024 |
| Società | Posizione | Fine |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
University College Cork
 University College Cork Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
